End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,14,600 KRW | +0.17% |
|
-1.21% | -8.69% |
10/06 | FDA Grants Fast Track Designation to GCBP and Novel Pharma's GC1130A | CI |
20/05 | Gc Biopharma and Novel Pharma Announce Sanfilippo Syndrome Treatment Obtains FDA IND Approval | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.69% | 94Cr | |
+55.19% | 81TCr | |
+47.26% | 65TCr | |
-6.09% | 35TCr | |
+21.92% | 34TCr | |
+18.40% | 25TCr | |
+3.64% | 23TCr | |
+12.98% | 22TCr | |
+10.86% | 17TCr | |
-2.78% | 16TCr |
- Stock Market
- Equities
- A006280 Stock
- News GC Biopharma Corp.
- Green Cross' Net Income Rises 3% in March Quarter